CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Cash Flows from Operating Activities:
Net (loss) income	$ (4,839)	$ 3,980
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	15,634	19,679
Provision for doubtful accounts	9,210	8,722
Non-cash compensation	1,500	3,280
401(k) employer match	3,048	4,363
Loss on disposal of property and equipment	2,688	708
Gain on sale of care centers	(2,967)	(357)
Deferred income taxes	(3,017)	2,959
Equity in earnings of equity investments	(1,671)	(700)
Amortization of deferred debt issuance costs	283	370
Return on equity investment	700	400
Other intangibles impairment charge	2,208	2,286
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable	(9,740)	35,684
Other current assets	(2,215)	(2,878)
Other assets	1,200	(800)
Accounts payable	414	(7,963)
U.S. Department of Justice settlement accrual	(115,000)	0
Accrued expenses	5,958	(4,293)
Other long-term obligations	1,135	537
Net cash (used in) provided by operating activities	(95,471)	65,977
Cash Flows from Investing Activities:
Proceeds from sale of deferred compensation plan assets	5	100
Proceeds from the sale of property and equipment	0	126
Purchases of deferred compensation plan assets	(67)	(74)
Purchases of property and equipment	(9,068)	(19,595)
Purchase of Investments	(2,495)	(6,227)
Acquisitions of businesses, net of cash acquired	0	(627)
Proceeds from dispositions of care centers, net of cash sold	2,233	2,082
Net cash used in investing activities	(9,392)	(24,215)
Cash Flows from Financing Activities:
Proceeds from issuance of stock upon exercise of stock options	88	113
Proceeds from issuance of stock to employee stock purchase plan	1,324	1,695
Non-controlling interest distribution	0	(93)
Proceeds from revolving line of credit	200,800	25,500
Repayments of revolving line of credit	(95,800)	(25,500)
Principal payments of long-term obligations	(7,627)	(27,904)
Net cash provided by (used in) financing activities	98,785	(26,189)
Net (decrease) increase in cash and cash equivalents	(6,078)	15,573
Cash and cash equivalents at beginning of period	17,303	14,545
Cash and cash equivalents at end of period	11,225	30,118
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	2,974	2,006
Cash paid for income taxes, net of refunds received	0	3,135
Supplemental Disclosures of Non-Cash Financing and Investing Activities
(Sale) acquisition of non-controlling interests	$ (1,549)	$ 167